Category Archives: MENA

Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia

Leave a reply

Agreement creates runway for Profound’s incision-free and radiation-free therapies for the ablation of diseased tissue, to penetrate the largest healthcare market in the Middle East

All required regulatory approvals to import and sell Profound’s two advanced ablative technologies in Saudi Arabia are already in place

TORONTO and RIYADH, Saudi Arabia, Nov. 11, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets artificial intelligence (“AI”)-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that it has entered into an exclusive distribution and supply agreement for its TULSA-PRO® and Sonalleve® technologies in Saudi Arabia with Al Faisaliah Medical Systems Co. (“FMS”), a subsidiary of one of the Kingdom’s most prominent business conglomerates, Al Faisaliah Group (“AFG”).

Profound is the only company that combines the real-time imaging and thermography capabilities of magnetic resonance (“MR”) with AI-driven treatment designs to allow physicians to precisely and gently address diseased tissue without any incision, associated tissue boiling or charring, blood loss, severe/prolonged pain, or need for overnight hospital stay.

U.S. commercialization of TULSA-PRO, designed specifically for the treatment of prostate disease (prostate cancer and/or benign prostatic hyperplasia, “BPH”), remains the top priority for the Company’s direct sales team. The TULSA Procedure™, performed using Profound’s TULSA-PRO system, is a significant advancement in prostate care. Instead of surgery or radiation, the TULSA procedure is performed inside an MRI suite to precisely and gently heat prostate tissue to ‘kill temperature’ (55-57°C) with directional ultrasound, while protecting surrounding nerves and anatomy. By intention-to-treat, while TULSA-PRO has the flexibility to be used for all ablations, including focal and hemi-gland, the majority of TULSA Procedures are either whole-gland or near-whole-gland ablations. In late 2024, the U.S. Centers for Medicare & Medicaid Services (CMS) issued its outpatient prospective payment system (OPPS) final rule (“Final Rule”) for the three new CPT® Category 1 codes and their descriptors covering the TULSA procedure, which became effective on January 1, 2025. With the Final Rule, TULSA reimbursement was established at Urology Level 7 Ambulatory Payment Classification (APC). To-date, more than 4,000 men have undergone the TULSA Procedure, and as of last report (October 2025), Profound’s TULSA-PRO installed base stood at 67 systems.

Profound’s second product, Sonalleve, which is offered primarily as a one-time capital sale, is also gaining increasing commercial interest, particularly outside of the United States. Sonalleve uses the same MR imaging and thermographic technology as TULSA-PRO, and combines that with focused ultrasound from outside the body to treat disease. There are currently ten Sonalleve devices operational in parts of Europe, China and Southeast Asia – where over 4,000 women have already been treated with the technology for adenomyosis and uterine fibroids, diseases of the uterus that can cause chronic pain and heavy and/or prolonged menstruations. Treatment with Sonalleve has demonstrated pain and symptom relief without affecting the ovarian reserve, and with reports of women preserving their fertility. Sonalleve is also now being used in research and clinical trials in Europe for the ablation of pancreatic cancer tissue and other oncological disease. Over the last five years, approximately $10 million has been granted by research organizations in Europe and Canada to further conduct clinical research using Sonalleve for multiple, often life-threatening, diseases.

As user interest in Profound’s technologies continues to build, the Company is deploying its own direct sales team in North America, while partnering with select strategic distribution partners to support the business potential and the customer base in other parts of the world.

“We’re honored to partner for the distribution of both TULSA-PRO and Sonalleve with FMS, one of the leading medical device distributors in the Kingdom of Saudi Arabia,” commented Profound’s CEO and Chairman, Arun Menawat. “Successfully marketing and distributing our incision-free therapies for the ablation of diseased tissue requires a deep understanding of regional market dynamics and the specific needs of local clinicians and patients. With its proven track record in introducing advanced oncological procedures and other medical technologies in the Kingdom, we’re confident that FMS is the ideal partner for us.”

FMS’ GM, Mr. Abdullah Al Melik, said, “As Saudi Arabia moves toward economic diversification under Vision 2030, both FMS and our parent company, AFG, are committed to playing a crucial role in shaping the country’s future. The group is a major provider of equipment and services to existing hospitals, and also actively owns and operates its own specialized medical facilities. With our partnership with Profound, we’re extremely excited to bring its unique, incision- and radiation-free ablative technologies to Saudi hospitals and treatment centers that aim to be worldwide leaders in patient outcomes. We look forward to working closely with the Profound team.”

About with Al Faisaliah Medical Systems Co.

Founded in 1973, FMS was initially the healthcare division of AFG, until its establishment as an independent company in 1993. Its broad portfolio of partners and products enables it to deliver complex, integrated, single-source healthcare equipment solutions to the largest healthcare providers in the region. With operations across the Kingdom of Saudi Arabia, FMS is a major provider of diversified healthcare solutions, supplying state-of-the-art equipment and solutions for various uses such as oncology, operations, monitoring and critical care, cardiovascular and others. For further information, visit www.tibbiyah.com/fms.

About Al Faisaliah Group

AFG is a privately held holding company headquartered in Riyadh, Saudi Arabia, operating across the wider Middle East. Its name is derived from the name of its founder, Abdullah Al Faisal, eldest son of the late King Faisal. Founded in 1971, the Group holds leading positions in multiple industries including Dairy, Electronics, Healthcare and Food Service. AFG also operates a corporate venture capital arm (Al Faisaliah Ventures) that invests in global and regional disruptive players. The Group is recognized across the region for its strongly-held values, professional management and decades-long strategic partnerships with leading local and global firms including notably Sony, Danone and Philips. For further information, visit www.alfaisaliah.com.

About Profound Medical Corp.

Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.

Profound is commercializing TULSA-PRO®, a technology that combines real-time MRI, AI-enhanced planning, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA Procedure™, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low-, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (“BPH”); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. The TULSA Procedure employs real-time MR guidance for precision to preserve patients’ urinary continence and sexual function, while killing the targeted prostate tissue via precise sound absorption technology that gently heats it to 55-57°C. The TULSA Procedure is an incision- and radiation-free “one-and-done” procedure performed in a single session that takes a few hours. Virtually all prostate shapes and sizes can be safely, effectively, and efficiently treated with the TULSA Procedure. There is no bleeding associated with the procedure; no hospital stay is required; and most TULSA patients report quick recovery to their normal routine. TULSA-PRO is CE marked, Health Canada approved, and 510(k) cleared by the U.S. Food and Drug Administration (“FDA”).

Profound is also commercializing Sonalleve®, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids, adenomyosis, pain palliation of bone metastases, desmoid tumors and osteoid osteoma. Sonalleve has also been approved by the China National Medical Products Administration for the non-invasive treatment of uterine fibroids and has FDA approval under a Humanitarian Device Exemption for the treatment of osteoid osteoma. Profound is in the early stages of exploring additional potential treatment markets for Sonalleve where the technology has been shown to have clinical application, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy.

Forward-Looking Statements

This release includes forward-looking statements regarding Profound and its business which may include, but is not limited to, the expectations regarding the efficacy of Profound’s technology in the treatment of prostate cancer, BPH, uterine fibroids, palliative pain treatment and osteoid osteoma; the extent and timing of Profound’s completion of TULSA-PRO® system sales from its qualified sales pipeline; Profound’s expectations for future revenues; and the success of Profound’s commercialization strategy and activities for TULSA-PRO. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “is expected”, “expects”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such statements are based on the current expectations of the management of Profound. The forward-looking events and circumstances discussed in this release, may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks regarding the medical device industry, regulatory approvals, reimbursement, economic factors, the equity markets generally and risks associated with growth and competition. Although Profound has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Other factors and risks that may cause actual results to differ materially from those set out in the forward-looking statements are described in Profound’s Annual Report on Form 10-K and other filings made with U.S. and Canadian securities regulators, available at www.sedarplus.ca and www.sec.gov. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Profound undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, other than as required by law.

For further information, please contact:

Stephen Kilmer
Investor Relations
skilmer@profoundmedical.com
T: 647.872.4849

GlobeNewswire Distribution ID 9573632

Industry leaders convene at Morocco’s second Showcase Summit to address 2030 hospitality supply opportunities

Leave a reply

Ahead of the 2025 Morocco Showcase Summit, industry leaders assess the kingdom’s readiness for 2030, analyzing investment and strategies to match demand

CASABLANCA, MOROCCO – EQS Newswire – 11 November 2025 – As hospitality and investment leaders prepare to gather at the Marriott Hotel in Casablanca for the Morocco Showcase Summit on November 19-20, 2025, a critical question takes center stage: Is Morocco’s hospitality supply growth keeping pace with its rapid infrastructure development and ambitious 2030 tourism targets?

With the nation poised to co-host the 2030 FIFA World Cup, the spotlight is on identifying investment strategies to fill the impending hospitality gap.

Morocco’s significant infrastructure advancements are creating new destinations and enhancing existing ones, demanding a parallel expansion in quality hospitality supply to accommodate the influx of visitors.

International hotel groups are answering the call.

Wyndham Hotels & Resorts is leveraging its diverse brand portfolio to bridge the supply gap. “We are committed to supporting Morocco’s Vision 2030 by expanding access to quality and affordable branded accommodation across both established and emerging destinations,” says Govind Mundra, head of development for Middle East & Africa at Wyndham Hotels & Resorts. “With our diverse portfolio of 25 brands and our Owner First franchising approach, we work closely with local developers to deliver trusted international standards that enhance Morocco’s hospitality offering.”

Wyndham’s strategy includes expanding its current presence in Moroccan cities, such as Fes and Tangier, into key cities like Casablanca, Marrakesh, and Rabat, with advanced discussions underway for new projects.

Similarly, Radisson Hotel Group has significantly elevated its ambitions. “We’ve lifted our Morocco ambition to 30 hotels by 2030, building on an already robust development pipeline and tightening our city-plus-coast focus,” says Erwan Garnier, Senior Director of Development, Africa at Radisson Hotel Group. The strategy involves “strengthening Casablanca and Marrakech while building out Rabat, Tangier, Agadir, and Fez with a mix of business hotels, serviced apartments, mixed-use projects, and resorts that track the country’s airport, rail, and stadium upgrades to 2030.”

For Radisson, the opportunity is clear. “Record tourism and the 2030 World Cup are concentrating demand along key corridors as airports expand and a new 115,000-seat stadium comes online,” Garnier notes.

For management companies like Aleph Hospitality, scaling operations is key to supporting this growth. A deeper, more responsive local presence is central to Aleph’s plan. “To better serve all hotels under our management in Morocco, we will be opening a regional office in the first quarter of 2026,” reveals Bani Haddad, Founder & MD of Aleph Hospitality. “This office will be led by a regional Vice President based in Morocco, who will drive development efforts, enhance operational performance, and ensure faster responsiveness to owners.”

This expansion is fuelled by strong investor relationships. Aleph Hospitality notes that more than 60% of its existing owners entrust multiple properties to its management, a testament to a trust-based approach focused on long-term value creation.

Beyond accommodation, the entire hospitality ecosystem requires investment. TGP International, known for its expertise in food and beverage (F&B) strategy for mega-events, is exploring opportunities to support Morocco’s tourism and hospitality value chain through strategic F&B planning and concept development.

“From F&B master planning for mega events to developing world-class restaurant concepts within hotels, our work explores emerging areas such as food halls, wellness F&B and gastrotourism to build ecosystems that strengthen the wider hospitality network,” says Simon Wright, Founder and Chairman of TGP International. He emphasizes that strategic F&B can “not only enhance the guest experience but also express national identity and cultural pride on the global stage.”

The consensus is clear: Morocco’s infrastructure growth presents an unparalleled opportunity. The path to 2030 will be paved by a collaborative effort from global brands, dedicated management companies, strategic consultants, and a diverse network of investors.

Distributed by APO Group on behalf of API Events.

Download Images:
https://apo-opa.co/445dNfs (Govind Mundra, Head of Development for Middle East & Africa at Wyndham Hotels & Resorts)

https://apo-opa.co/4qS1ayh (Erwan Garnier, Senior Director of Development, Africa at Radisson Hotel Group)

Note to investors:

Contact Murray at murray@apievents.com to secure your complimentary seat at the Morocco Showcase Summit.

The issuer is solely responsible for the content of this announcement.

About the Morocco Showcase Summit:

The Morocco Showcase Summit is the premier gathering for international investors, developers, financiers, and hospitality leaders to explore investment and partnership opportunities in Morocco’s rapidly evolving tourism and infrastructure landscape. The event facilitates the connections and insights necessary to drive the nation’s growth.

Website: www.APIEvents.com

 

‫يشارك مجمع هونغ كونغ للعلوم والتكنولوجيا في وفد هونغ كونغ الذي يزور المملكة العربية السعودية، لتعزيز الابتكار وتوسيع آفاق الاستثمار خلال الدورة التاسعة من مبادرة مستقبل الاستثمار.

Leave a reply
 هونغ كونغ- 11 نوفمبر 2025 – يؤكد مجمع هونغ كونغ للعلوم والتكنولوجيا التزامه برعاية الشركات والمواهب التكنولوجية، ودفع عجلة تطوير منظومة الابتكار والتكنولوجيا المحلية، مع مواصلة دعم شركات المجمع في استكشاف الأسواق الدولية، والاستفادة من دور هونغ كونغ كحلقة وصل بين العالم والصين القارية، واستكمالًا للنجاح الذي أحرزته الزيارة السابقة، انضمت 13 شركة من شركات مجمع هونغ كونغ للعلوم والتكنولوجيا إلى وفد قادَه وزير المالية الصيني بول تشان في الفترة من 27 إلى 31 أكتوبر، في زيارة إلى الرياض بالمملكة العربية السعودية للمشاركة في الدورة التاسعة من مبادرة مستقبل الاستثمار.

انضمت 13 شركة من شركات مجمع هونغ كونغ للعلوم والتكنولوجيا إلى وفد قادَه وزير المالية الصيني بول في زيارة إلى الرياض بالمملكة العربية السعودية، للمشاركة في الدورة التاسعة من مبادرة مستقبل الاستثمار.”

يواصل مجمع هونغ كونغ للعلوم والتكنولوجيا تعاونه مع مجلس تنمية التجارة في هونغ كونغ بعد أن قادا معًا 22 مؤسسة تكنولوجية من هونغ كونغ للمشاركة في اثنين من أبرز فعاليات الابتكار والتكنولوجيا في دبي، هما جيتكس غلوبال وإكسباند نورث ستار، وجاءت الزيارة الجديدة إلى الرياض تأكيدًا على التزام الجانبين بتوسيع التعاون مع منطقة الشرق الأوسط، وتُعد مبادرة مستقبل الاستثمار منصة عالمية تجمع صانعي القرار في السياسة والأعمال والمستثمرين ورواد الابتكار من مختلف أنحاء العالم لمناقشة الاتجاهات الاقتصادية المستقبلية واستكشاف فرص الاستثمار.

 التقى الدكتور مارتن تشو، الشريك المؤسس والرئيس التنفيذي لشركة آي تو كول مع الغرف والمؤسسات المحلية، وتمكن من توقيع مذكرة تفاهم مع شركة مدار لمواد البناء.

واصلت شركات المجمع تعزيز منظومة الابتكار والتكنولوجيا في هونغ كونغ نحو صانعي القرار وقادة الأعمال في الشرق الأوسط من خلال مشاركتها في هذا المؤتمر رفيع المستوى، مستكشفة الفرص المحتملة في الاستثمار التكنولوجي، والتعاون في البحث والتطوير، وتوسيع الأسواق، حيث حققت شركة آي تو كول وهي شركة من شركات المجمع تقدمًا ملموسًا بتوقيع مذكرة تفاهم ناجحة مع شركة مدار لمواد البناء، بينما استعرضت شركة ويستويل تكنولوجي، والتي سبق لها زيارة الشرق الأوسط العام الماضي، رحلتها التنموية خلال فعاليات مبادرة مستقبل الاستثمار هذا العام.

تتخصص شركة ويستويل تكنولوجي في تقديم حلول الطاقة الجديدة المؤتمتة، وقدّم يانغ مينغ، الرئيس التنفيذي لشركة ويستويل القابضة (هونغ كونغ) خلال فعاليات مبادرة مستقبل الاستثمار، عرضًا بعنوان “الانطلاق نحو مستقبل أكثر استدامة للذكاء الاصطناعي والطاقة المتجددة”، استعرض فيه رؤى حول دمج الذكاء الاصطناعي والطاقة لدفع التحول الأخضر في قطاع الخدمات اللوجستية، وتشمل أنشطة الشركة حاليًا 28 دولة ومنطقة، بما في ذلك سوق الشرق الأوسط.

قدمت هذه الزيارة إنجازًا بارزًا لمجمع هونغ كونغ للعلوم والتكنولوجيا وقطاع الابتكار والتكنولوجيا في هونغ كونغ، حيث ساهمت في توطيد أواصر التعاون مع الشرق الأوسط، وتوسيع شبكة التعاون العالمية، وتمهيد الطريق لمرحلة جديدة في تطوير منظومة الابتكار والتكنولوجيا في هونغ كونغ

نبذة عن مجمع هونغ كونغ للعلوم والتكنولوجيا

تأسس مجمع هونغ كونغ للعلوم والتكنولوجيا عام 2001، وأسّس منظومة مزدهرة للابتكار والتكنولوجيا في هونغ كونغ، داعمًا 13 شركة من الشركات أحادية القرن (اليونيكورن)، وراعيًا نحو 15,000 موهبة بحثية، ومستضيفًا أكثر من 2,400 شركة تكنولوجية من 25 دولة ومنطقة، متخصصة في مجالات الطب الحيوي، والذكاء الاصطناعي والروبوتات، والتكنولوجيا المالية، وتطوير المدن الذكية، ويكرّس مجمع هونغ كونغ للعلوم والتكنولوجيا جهوده لتعزيز مكانة هونغ كونغ حيث يمثل مركزًا عالميًا في قطاع الابتكار والتكنولوجيا.

ويسعى مجمع هونغ كونغ للعلوم والتكنولوجيا لجذب ورعاية المواهب في مجالات الابتكار والتكنولوجيا، وتسريع تحويل الابتكارات إلى تطبيقات عملية، إلى جانب تقديم دعم متكامل للشركات التكنولوجية والمحترفين خلال رحلتهم نحو التميّز والابتكار، يأتي ذلك انسجامًا مع رؤية هونغ كونغ المستقبلية، بالإضافة إلى تعزيز نمو منظومته المتقدمة للابتكار والتكنولوجيا، حيث يضم مجمع هونغ كونغ للعلوم في باك شيك كوك، ومركز إنوسنتر في كولون تونغ، وثلاثة مراكز إينوبارك في تاي بو، ويوين لونغ، وتسوانغ كووان أو، وتعمل هذه المنشآت على دفع عجلة التقدم في التكنولوجيا التطبيقية، مع تركيز خاص على صناعات التصنيع المتقدم، والميكروإلكترونيات، والتكنولوجيا الحيوية، ممهِّدة الطريق أمام هونغ كونغ لدخول مرحلة صناعية جديدة ومبتكرة.

ويستفيد فرع مجمع هونغ كونغ العلمي في شنتشن، الكائن في منطقة فوتيان، من الميزة الاستراتيجية المتمثلة في “الاستفادة من دعم الوطن الأم والانفتاح على العالم”، ليكون حلقة الوصل التي تربط بين الشركات المحلية والعالمية ويشجع التعاون الدولي في مجالات الابتكار والتكنولوجيا، ويوفر الفرع للشركات العالمية والمحترفين مساحات متكاملة للبحث والعمل المشترك، مع تركيز خاص على سبعة قطاعات رئيسية تشمل: التكنولوجيا الطبية، والبيانات الضخمة والذكاء الاصطناعي، والروبوتات، والمواد الجديدة، والميكرو إلكترونيات، والتكنولوجيا المالية، والتنمية المستدامة.

يكرّس مجمع هونغ كونغ للعلوم والتكنولوجيا جهوده لدفع تطوير منظومة الابتكار والتكنولوجيا في هونغ كونغ، من خلال توفير البنية التحتية البحثية، وخدمات دعم الشركات الناشئة والمؤسسات، والخبرات المهنية في الاستثمار والأعمال، وتعزيز شبكات الشراكات، واستقطاب أفضل الكفاءات، وتسهم هذه الجهود في جعل الابتكار محركًا جديدًا للنمو الاقتصادي في هونغ كونغ.

لمزيد من المعلومات عن مجمع هونغ كونغ للعلوم والتكنولوجيا، يُرجى زيارة الموقع الإلكتروني: www.hkstp.org.

Saudi Arabia Joins Global Framework for Close-Out Netting

Leave a reply

RIYADH, Saudi Arabia, Nov. 11, 2025 (GLOBE NEWSWIRE) — The International Swaps and Derivatives Association (ISDA) has published its legal opinions that recognize the enforceability of close-out netting in Saudi Arabia, a move that provides global financial institutions with greater legal certainty when transacting in the Kingdom’s Derivatives Market. The decision follows the Capital Market Authority’s (CMA) issuance of the (Close-out Netting and related Collateral Arrangements Regulation) this year.

Close-out netting allows counterparties in a qualified financial contract to offset their obligations if one party defaults, leaving only a single net payment due. Thus, reducing systemic risk and ensures the orderly settlement of contracts. Additionally, its enforceability determines whether international investors can manage their exposures efficiently.

The CMA regulation that was published establishes a legal recognition of netting and related Financial collateral arrangements where one party is a capital market institution. It also aims to enhance the stability of the financial system and protect investors by ensuring the enforceability of a qualified financial contracts thereby safeguarding the rights of all parties involved.

Mr. Raed Alhumaid, CMA Deputy for Market Institutions, said that the development reflects Saudi Arabia’s ongoing effort to strengthen the foundations of its financial system. He added, “We welcome ISDA’s legal opinions that recognize the enforceability of close-out netting in the Kingdom of Saudi Arabia, following the issuance of our (Close-out Netting and Related Collateral Arrangements Regulation) this year.”

For international institutions, the recognition of enforceable netting in Saudi Arabia reduces counterparty uncertainty and supports broader participation in the local derivatives markets, creating the legal foundation necessary for market depth and liquidity growth.

It is worth noting that Saudi Arabia’s derivatives market was launched in 2020 with the MT30 Index Futures, followed by single stock futures (SSF) in 2022 and single stock options (SSO) in 2023. These instruments expanded investors’ ability to hedge and manage risk. The enforceable netting framework strengthens this market by ensuring greater legal certainty in derivatives transactions and supporting its continued growth and stability.

The CMA noted in its press release that the regulation includes a set of provisions governing close-out netting and associated collateral arrangements, defines its scope of application and the entities subject to it, and defines qualified financial contracts and transactions that would be exempt from the provisions of the Bankruptcy Law. This step is expected to contribute to enhancing the stability and sustainability of the Kingdom’s financial sector and the overall capital market framework.

Capital Market Authority

Communication & Investor Protection Division

+966114906009

+966557666932

Media@cma.org.sa

www.cma.org.sa


GlobeNewswire Distribution ID 9573142

خلال تخفيضات يوم العُزّاب EZVIZ ارتقِ بمنزلك الذكي مع حماية موثوقة: عروض لا تُفوَّت من في منطقة الشرق الأوسط وشمال إفريقيا

Leave a reply

دبي، الإمارات العربية المتحدة،, Nov. 11, 2025 (GLOBE NEWSWIRE) —

 تُشعل شركة EZVIZ، الرائدة عالميًا في حلول الأمن والحياة الذكية للمنازل، أجواء تخفيضات يوم العُزّاب هذا العام بعروض استثنائية عبر منصّتي Amazon MENA وNoon. وتستمر الحملة من 7 إلى 13 نوفمبر، لتمنح المتسوقين الفرصة المثالية لاقتناء أجهزتهم الذكية المفضلة من EZVIZ بأسعار مذهلة قبل فوات الأوان.

من الكاميرات وأجراس الفيديو الذكية إلى الأقفال الذكية المتقدمة، تغطي تشكيلة EZVIZ لهذا العام مجموعة واسعة من ابتكارات المنازل الذكية، والتي صُممت معظمها لتعزيز أمان المنازل وراحة البال. سواء كنت ترغب في ترقية مدخل المنزل أو مراقبة جميع الزوايا، تقدّم EZVIZ منتجات موثوقة تجلب الحماية الذكية إلى متناول يدك.

كاميرا C6N الذكية بتقنية Wi-Fi

تُعد C6N الخيار الأسهل للانطلاق نحو حياة ذكية. فهي كاميرا داخلية توفر رؤية شاملة للغرفة وتمكّنك من مراقبة أمان منزلك عن بُعد في أي وقت ومن أي مكان. بفضل خاصية تتبع الحركة الذكي والرؤية الليلية، تبقيك الكاميرا على اتصال دائم بمنزلك، سواء كنت في العمل أو في رحلة أو حتى في الجوار.

القفل الذكي ببصمة الإصبع Y2000

اجعل باب منزلك أكثر ذكاءً وأمانًا. يقدّم Y2000 مستوى جديدًا من الراحة من خلال فتح القفل ببصمة الإصبع وإمكانية التحكم عن بُعد عبر تطبيق EZVIZ. وبعد تركيبه، يمكنه الاندماج بسلاسة مع كاميرا C6N، مما يتيح لك مراقبة المدخل وإدارة الوصول ضمن منظومة ذكية متكاملة.

القفل الذكي بالتعرّف على الوجه DL50

لمن يبحثون عن أحدث تقنيات الوصول الآمن، يقدّم DL50 ميزة فتح الباب عبر التعرّف على الوجه، ليتعرف على المستخدم ويفتح الباب فورًا. كما يدعم القفل طرق فتح متعددة تشمل التطبيق على الهاتف، وكلمة المرور، وبصمة الإصبع، والمفتاح التقليدي، ليجمع بين المرونة والأمان للعائلات العصرية.

الجرس المرئي الذكي CP7

يُعد CP7 حارس الباب الذكي الذي يسهّل عليك رؤية الزوّار والتحدث إليهم من أي مكان. تم تصميمه خصيصًا للمنازل الكبيرة والفيلات، ويوفر رؤية واضحة وتواصلاً فوريًا عبر تطبيق EZVIZ. كما يمكن ربطه مع الأقفال الذكية من EZVIZ لتتمكن من فتح الباب عن بُعد وإدارة الدخول بلمسة واحدة، مما يجمع بين الراحة والأمان عند عتبة منزلك.

مع التزامها الدائم بالابتكار والجودة، تواصل EZVIZ مساعدة العائلات في منطقة الشرق الأوسط وشمال إفريقيا على تبنّي أسلوب حياة أكثر ذكاءً وأمانًا. لا تفوّت الفرصة لترقية منزلك، فـ تخفيضات يوم العُزّاب متاحة الآن على Amazon MENA وNoon حتى 13 نوفمبر.

جهة الاتصال
lixiaolan15@ezviz.com

GlobeNewswire Distribution ID 9573082

Upgrade your smart home with reliable protection: EZVIZ brings unmissable deals this Singles’ Day Sale across MENA

Leave a reply

DUBAI, United Arab Emirates, Nov. 10, 2025 (GLOBE NEWSWIRE) — EZVIZ, a global leader in smart home security and lifestyle solutions, is lighting up this year’s Singles’ Day Sale with can’t-miss deals across Amazon MENA and Noon. The sale is ongoing from November 7 to 13, giving shoppers the perfect chance to grab their favorite EZVIZ smart gadgets at incredible prices before it’s too late.

From cameras and video doorbells to advanced smart locks, this year’s Singles’ Day lineup spans multiple categories of smart home innovations, most of which are designed to enhance household safety and peace of mind. Whether upgrading your home’s entryway or keeping an eye on every corner, EZVIZ offers trusted products that bring smart protection within reach.

C6N Smart Wi-Fi Camera
The C6N is the easiest gadget to step into your smart living. This camera offers complete room coverage, letting you check your home’s security remotely anytime, anywhere. With intelligent motion tracking and night vision, it keeps you connected and reassured, whether you’re at work, traveling, or relaxing next door.

Y2000 Fingerprint Smart Lock
Make your front door smarter and safer. The Y2000 introduces a new level of convenience with fingerprint unlocking and remote control through the EZVIZ App. Once connected, it can also integrate seamlessly with your C6N camera, allowing you to monitor the entrance and manage access in one smart ecosystem.

DL50 Face Recognition Smart Lock
For those who want the latest in secure access, the DL50 recognizes who you are to open the door. It also supports multiple unlocking methods, including mobile app, password, and traditional key, offering both flexibility and peace of mind for modern households.

CP7 Video Doorphone
A smart doorkeeper that makes it easy to see and talk to visitors from anywhere. Designed especially for large homes and villas, it provides clear visuals and instant communication through the EZVIZ App. You can also pair it with EZVIZ smart locks to remotely unlock your door and manage access with just a tap—bringing convenience and security together at your doorstep.

With innovation and quality at its core, EZVIZ continues to help families in the MENA region embrace the future of secure, intelligent living. Don’t miss your chance to upgrade your home, the Singles’ Day Sale is now live on Amazon MENA and Noon through November 13.

Contact:

Charlene Li
lixiaolan15@ezviz.com

GlobeNewswire Distribution ID 9573082

North Atlantic France SAS provides updates on the contemplated acquisition of a majority stake in Esso Société Anonyme Française SA

Leave a reply

Paris, France, Nov. 10, 2025 (GLOBE NEWSWIRE) —

North Atlantic France SAS provides updates on the contemplated acquisition of a majority stake in Esso Société Anonyme Française SA 

  • Turkish antitrust clearance obtained; transaction remains subject to French direct foreign investment authorization and EU Foreign Subsidies clearance
  • Transaction target closing date set for November 28, 2025
  • Esso S.A.F. shareholders approved extraordinary distribution of €60.21 per share
  • Assuming a closing on November 28, 2025, final purchase price of €26.19 per Esso S.A.F. share for the acquisition of the ExxonMobil block of shares and €28.93 per Esso S.A.F. share in the context of the tender offer
  • Esso S.A.F. to be renamed “North Atlantic Energies” upon completion of the transaction

Paris, FRANCE, November 10, 2025 – North Atlantic France SAS (“North Atlantic”) refers to its announcements dated May 28, 2025, September 24, 2025 and October 6, 2025 with respect to the contemplated acquisition from ExxonMobil France Holding SAS (“ExxonMobil”) of ExxonMobil’s entire stake in Esso Société Anonyme Française SA (“Esso S.A.F.”) and in ExxonMobil Chemical France SAS (the “Transaction”).

Regulatory approvals and expected closing timeline

North Atlantic has obtained Turkish antitrust clearance and continues to pursue the remaining regulatory approvals, namely the foreign investment prior authorization from the French Ministry of Economy and the decision of the European Commission under the EU Foreign Subsidies Regulation.

Subject to obtaining these approvals and finalizing certain financing arrangements, North Atlantic and ExxonMobil currently expect to close the Transaction on November 28, 2025.

Block acquisition purchase price of €26.19 per share assuming a closing on November 28, 2025

On October 6, 2025, North Atlantic announced that the price per Esso S.A.F. share of €149.19 would be reduced to €85.18 reflecting (i) a €11.01 downward adjustment for the change in the euro value of Esso S.A.F.’s inventory relative to its value as of December 31, 2024 and (ii) a €53.00 downward adjustment corresponding to the ordinary dividend and the extraordinary dividend paid by Esso S.A.F. on July 10, 2025.

In addition, taking into account the €60.21 per share extraordinary distribution to be paid on November 14, 2025 by Esso S.A.F., following shareholder approval obtained on November 4, 2025 at Esso S.A.F.’s Combined General Meeting, the €85.18 price per share will be further reduced to €24.97.

     Assuming a closing on November 28, 2025, North Atlantic and ExxonMobil have agreed to definitively settle between themselves, on a lump-sum basis, the amount of the price adjustments provided for in the Share Purchase Agreement and to set the price per share to be paid to ExxonMobil at €26.19.1

     On this basis, the price to be paid to Esso S.A.F.’s minority shareholders in the mandatory tender offer for the remaining Esso S.A.F. shares that North Atlantic intends to file before the end of the year is set at €28.932 per share, corresponding to a difference of approximately 10.46% over the price per share paid to ExxonMobil.

Change of corporate name of Esso S.A.F

As resolved at Esso S.A.F.’s Combined General Meeting on November 4, 2025 and subject to completion of the Transaction, Esso S.A.F. will be renamed “North Atlantic Energies.”

North Atlantic reiterates its commitment to delivering a comprehensive and well-managed transition, with the intention to maintain employment and existing compensation and benefits.

MEDIA CONTACTS

France: Brunswick Group – northatlantic@brunswickgroup.com
Hugues Boëton: +33 6 79 99 27 15
Paul Priam: +33 6 84 39 09 89

Canada: Mark Duggan – markduggan@northatlantic.ca
+1-709-687-3136

ABOUT NORTH ATLANTIC
For nearly four decades, North Atlantic has been a market leader in the retail gas and convenience sector, as well as the residential, commercial, and wholesale fuel industries in Newfoundland and Labrador. Recently, through a joint venture with Suncor Energy, North Atlantic expanded its retail division into Nova Scotia and Prince Edward Island, through North Sun Energy. As managing partner, North Atlantic operates 110 fuel retail sites across all three provinces. North Atlantic has ambitious plans for future growth and development in strategic locations across the region.

Known for its expertise in acquiring and delivering exceptional products, North Atlantic caters to both domestic and industrial sectors while also serving global clients through their marine bunkering distribution channels.

North Atlantic is committed to strategic growth to deliver innovative and green energy solutions aligned with evolving global needs. By driving industry progress, North Atlantic is supporting new skills and new jobs for this dynamic landscape. North Atlantic remains committed to providing exceptional energy, fuel and convenience retail initiatives that enhance customer experience while fostering economic growth in the communities they serve in Canada and beyond.

1 For the avoidance of doubt, if closing does not occur on November 28, 2025, the price per share to be paid to ExxonMobil will have to be recalculated in accordance with the terms and conditions of the Share Purchase Agreement entered into between ExxonMobil and North Atlantic on September 24, 2025. These adjustments are described in the press release issued by North Atlantic on 6 October 2025. As a reminder (excluding the adjustment referred to in note 2 below, which does not affect the price paid as part of the tender offer), these adjustments relate to:

  • an upward adjustment by a ticking fee mechanism corresponding to accrued interest on (i) a first base amount of €362,000,000 at an interest rate based on the euro short-term rate (ESTR) plus 2% per annum between March 2, 2025 (included) and the closing date (excluded), and (ii) a second base amount of €950,000,000 at a rate of 2.4% per annum between March 2, 2025 (included) and the closing date (excluded);
  • an upward adjustment reflecting an after tax impact amount of (i) the sale to the ExxonMobil group of Esso S.A.F.’s lubricants and specialties marketing business for an estimated price of €8 million (including €3 million for inventories, to be further adjusted at the closing date) and (ii) the sale to the ExxonMobil group of certain trademarks and other intellectual property rights of Esso S.A.F. for an amount of €20 million.

2 This price difference results from the exclusion, with regard to the price paid to the minority shareholders, of the impact of the downward adjustment on the price payable to ExxonMobil with respect to losses relating to post-closing social liabilities as previously announced on September 24, 2025.

MEDIA CONTACTS

France: Brunswick Group - northatlantic@brunswickgroup.com
Hugues Boëton: +33 6 79 99 27 15
Paul Priam: +33 6 84 39 09 89

Canada: Mark Duggan - markduggan@northatlantic.ca
+1-709-687-3136

GlobeNewswire Distribution ID 9572706

Tres Thompson joins Meltwater as Chief Financial Officer

Leave a reply

SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Meltwater, a leading global provider of media, social, and consumer intelligence, today announced the appointment of Tres Thompson as Chief Financial Officer (CFO). With over 35 years of experience in accounting, finance, and operational leadership within both privately held and publicly traded technology companies, Thompson brings a wealth of expertise to the Meltwater Executive Team.

Most recently, Thompson served as CFO of HighRadius, a global SaaS company specializing in AI solutions for the office of the CFO. Prior to that, he held the position of CFO at Velsera, a health technology company, and was CFO and COO at Symplr, a SaaS platform serving the healthcare industry. Tres brings significant experience leading high-growth, private-equity backed organizations to successful exits, as well as M&A and integration expertise, to his new role at Meltwater.

“I’m excited to join Meltwater at such a dynamic moment in the company’s growth journey,” said Tres Thompson, CFO of Meltwater. “The products, the people and the history of profitable growth create incredible opportunities to continue to scale, drive operational excellence and create long-term value.”

“Tres brings deep financial and operational experience that will be instrumental as we continue to drive sustainable growth at Meltwater,” said John Box, CEO of Meltwater. “His track record and history of results at high-growth, global SaaS organizations make him a strong addition to our leadership team.”

Thompson will lead Meltwater’s global central operations and finance organizations, overseeing financial strategy, operations, and investor relations as the company continues to strengthen its position as a leader in AI-powered media and social intelligence.

For more information, please contact:

Kelly Costello
Corporate Communications Director
pr@meltwater.com

About Meltwater

Meltwater empowers companies with a suite of solutions that spans media, social, consumer, and sales intelligence. By analyzing approximately 1 billion pieces of content each day and transforming them into vital insights, Meltwater unlocks the competitive edge to drive results. With 27,000 global customers, 50 offices across six continents, and 2,300 employees, Meltwater is the industry partner of choice for global brands making an impact. Learn more at meltwater.com.

GlobeNewswire Distribution ID 9572473

Azurity Pharmaceuticals Names Ogilvy Health as PR and Marketing Agency of Record to Drive Strategic Brand Repositioning and Enhance Market Visibility

Leave a reply

New York, NY and Woburn, MA, Nov. 10, 2025 (GLOBE NEWSWIRE) — Azurity Pharmaceuticals names Ogilvy Health as public relations and marketing agency of record. Ogilvy Health’s mandate will focus on reimagining Azurity’s brand story centered on patient commitment and pioneering growth. The agency will also enhance Azurity’s external visibility – both online and offline – and oversee the development of a new website to deliver dynamic content to all stakeholders, ensuring measurable impact across every channel.

Azurity is a high-growth global pharmaceutical company dedicated to creating new opportunities and markets for a broad range of established medications, while also developing innovative treatments for overlooked patient populations. Azurity’s goal is to identify gaps in care and provide patients with medicines that improve efficacy, access, safety, or the patient experience.

With a portfolio of over 50 medicines across 10 dosage forms and 10 key therapeutic areas, Azurity leverages data and AI to navigate markets, ensure stakeholder engagement, and expand our reach. Today, Azurity serves patients in over 50 countries worldwide, through a mix of direct and indirect go-to-market models, and our efforts are making a significant impact. Azurity’s medicines have benefited millions of people globally and that number continues to grow exponentially.

Ronald Scarboro, CEO of Azurity Pharmaceuticals said: “We are entering a pivotal phase in Azurity’s growth, and selecting the right strategic communications partner was essential. Ogilvy Health brings world-class expertise in healthcare brand repositioning, a compelling vision for elevating our market presence, and a truly global reach—making them an ideal partner for our continued evolution. Their team understands our ambition to honor our strong heritage while confidently advancing into the future. We are confident that their partnership will be instrumental in shaping a clear and unified identity that resonates with healthcare professionals, patients, partners, and investors alike.”

Shannon Walsh, President of Public Relations, Social and Influence at Ogilvy Health added: “Ogilvy Health is known for building some of the world’s biggest brands and that happens because we seek out partners like Azurity with tangible momentum and a clear ambition to reshape their business to better serve patients. Together, we will build an insight-led platform that grows with the Azurity brand, uniting our twin peaks of creativity and effectiveness, to help Azurity stake their claim as a global industry pioneer and drive meaningful impact across all critical audiences.”

In 2025, Ogilvy was recognized as the most creative and most effective agency network in the world, ranking #1 on WARC’s Creative 100 and Effective 100 lists for the fifth year in a row. The WARC 100 lists act as an industry benchmark for success based on results from the most prestigious global and regional industry competitions.

About Azurity Pharmaceuticals
Azurity Pharmaceuticals is a privately held global pharmaceutical company dedicated to developing and delivering innovative, patient-centric medicines that meet unmet needs, particularly for populations requiring customized dosing or alternative formulations. With a portfolio of over 50 medicines focused on quality, safety, and ease of use, Azurity provides healthcare professionals with reliable treatment options across 10 therapeutic areas. The company’s mission centers on improving patient outcomes through thoughtfully designed, clinically meaningful medications. For more information, visit www.azurity.com.

About Ogilvy Health
Ogilvy Health is focused on driving superior outcomes in the ever-changing healthcare environment, an increasingly complex and evolving marketplace. We inspire brands and people to impact the world by keeping our audiences’ health and wellness needs at the center of every touchpoint. Ogilvy Health delivers insight, creativity, innovation, and engagement solutions for all healthcare stakeholders, patients, and consumers across the healthcare continuum. Through borderless creativity— operating, innovating, and creating at the intersection of Ogilvy’s capabilities and global talent—Ogilvy Health brings forth world-class creative solutions for its clients. For more information, visit OgilvyHealth.com, or follow Ogilvy Health on X, LinkedIn, Facebook, Instagram, and Threads.

Tara Mullins
Ogilvy
tara.mullins@ogilvy.com

GlobeNewswire Distribution ID 9572390

2025 JETOUR Media Alliance Tech Tour Concludes Successfully

Leave a reply

Media workshop on future hybrid off-road mobility

Media workshop on future hybrid off-road mobility

WAHU, China, Nov. 10, 2025 (GLOBE NEWSWIRE) — The 2025 JETOUR Media Alliance (JMA) Tech Tour successfully concluded in Wuhu, Anhui Province. The event brought together representatives from leading automotive media worldwide at JETOUR’s headquarters. Through a series of technology immersions, workshops, and test drives, participants gained a systematic understanding of JETOUR’s latest advancements in new energy and hybrid off-road technologies, as well as its global strategy.

Demonstrating Technical Strength: The GAIA Architecture Defines Next-Generation Hybrid Off-Road

A core component of the Tech Tour was a comprehensive presentation of GAIA architecture. This architecture integrates four core modules — the GAIA Platform, GAIA Cockpit, GAIA Pilot, and GAIA Travel+ — and was engineered to meet the all-terrain mobility demands of the new energy era.

The G700, an all-terrain premium hybrid off-road SUV built on the GAIA Architecture, became the centerpiece of the event.

During the first global media test-drive, the G700 won broad recognition for its robust power delivery and intelligent control systems, fully demonstrating JETOUR’s technical credibility and brand confidence in the premium hybrid off-road segment.

Amplifying Global Voices: JMA Deepens Collaboration

The Tech Tour also marked a significant milestone in the collaboration within the JETOUR Media Alliance (JMA). During the event, JETOUR organized multiple workshops for in-depth exchanges with global media.

This combination of seminars and hands-on experiences provided guests with a more intuitive grasp of JETOUR’s technical roadmap and strategic direction in the hybrid off-road field. Many noted that the G700 achieves an exceptional balance of performance, intelligence, and efficiency, highlighting its strong competitive edge in markets like the Middle East and Africa, where long range and superior off-road capability are paramount. Media representatives from Saudi Arabia, Egypt, and Chile also shared valuable local user feedback on off-road performance, range, and intelligent features, providing crucial insights for JETOUR’s ongoing product refinement and globalization.

With the G700 poised for its global debut, JETOUR is accelerating toward its vision of becoming the world’s leading hybrid off-road brand. Backed by a “6+N” global R&D system and a team of 4,000 innovators, the brand now operates in 91 countries and regions with 8 overseas subsidiaries — strengthening its global network and redefining hybrid off-road standards worldwide.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3e1eabde-2b47-4fbb-b37d-adb49a8e5412

Contact:
JETOUR Auto
Weitong Liu
liuweitong@mychery.com
https://www.jetour.com.cn/

GlobeNewswire Distribution ID 9572380